title: Epidermal growth factor modulation of prostaglandins and nitrite biosynthesis in rat fetal membranes.
abstract: The production of prostaglandins (PGs) and nitric oxide (NO) by amnion tissue may play a significant role in parturition. It is thought that epidermal growth factor (EGF) may be one of the fetal signals that governs the initiation of labor. The aim of the present study was to investigate the effect of EGF in vivo on the PGs and nitrite production of rat fetal membranes. We have evaluated the regulation of PGs and nitrite production in rat fetal membranes ex vivo. The intra-uterine administration of EGF 500 ng in day 21 of pregnancy induced increases in PGE(2) (P<0.001) and PGF(2alpha) (P<0.01) compared to the control fetal membranes from pregnant rats on day 22. Also, this dose of EGF diminished nitrate production significantly (P<0.01). We found that fetal membranes at term (days 18-22 of gestation) expressed EGF-R. The NO donor, nitroprussiate 300 and 600 microM, elicited an inhibitory effect on the PGE(2) and PGF(2alpha) stimulated synthesis. On the other hand, indomethacin 10(-6) and 10(-7)M, a non-selective cyclooxygenase inhibitor, reverted the inhibitory effect exerted by EGF. Hence, rat fetal membranes were found to express epidermal growth factor receptors and, under the effect of EGF, PGs and nitrites production pathways interact probably to prevent a toxic effect caused by an exacerbated synthesis of these mediators.
authors.affiliation: Laboratorio de Fisio-patología de la preñez y el parto, Centro de Estudios Farmacológicos y Botánicos, Serrano 669, 3rd floor, CP (C1414DEM), Bs As, Argentina. marialribeiro@yahoo.com.ar
authors.forename: M L
authors.initials: ML
authors.lastname: Ribeiro
authors.forename: D
authors.initials: D
authors.lastname: Ogando
authors.forename: M
authors.initials: M
authors.lastname: Farina
authors.forename: A
authors.initials: A
authors.lastname: Franchi
mesh_terms: D000818:Animals; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000494:pharmacology*; D066246:ErbB Receptors / Q000378:metabolism; D005321:Extraembryonic Membranes / Q000187:drug effects* / Q000196:embryology / Q000378:metabolism*; D005260:Female; D007213:Indomethacin / Q000494:pharmacology; D007527:Isoenzymes / Q000378:metabolism; D009566:Nitrates / Q000378:metabolism*; D020030:Nitric Oxide Donors / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000378:metabolism; D009599:Nitroprusside / Q000494:pharmacology; D011247:Pregnancy; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D009566:Nitrates; D020030:Nitric Oxide Donors; D011453:Prostaglandins; D009599:Nitroprusside; D004815:Epidermal Growth Factor; D019001:Nitric Oxide Synthase; D011451:Prostaglandin-Endoperoxide Synthases; D066246:ErbB Receptors; D007213:Indomethacin